KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Merck (MRK) Shares Outstanding (2016 - 2026)

Merck has reported Shares Outstanding over the past 18 years, most recently at $3.6 billion for Q1 2026.

  • Quarterly Shares Outstanding changed 0.0% to $3.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.6 billion through Mar 2026, changed 0.0% year-over-year, with the annual reading at $3.6 billion for FY2025, 0.0% changed from the prior year.
  • Shares Outstanding was $3.6 billion for Q1 2026 at Merck, roughly flat from $3.6 billion in the prior quarter.
  • Over five years, Shares Outstanding peaked at $3.6 billion in Q3 2025 and troughed at $3.6 billion in Q1 2022.
  • The 5-year median for Shares Outstanding is $3.6 billion (2022), against an average of $3.6 billion.
  • Year-over-year, Shares Outstanding changed 0.0% in 2022 and then increased 0.0% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $3.6 billion in 2022, then changed by 0.0% to $3.6 billion in 2023, then changed by 0.0% to $3.6 billion in 2024, then increased by 0.0% to $3.6 billion in 2025, then changed by 0.0% to $3.6 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Shares Outstanding are $3.6 billion (Q1 2026), $3.6 billion (Q4 2025), and $3.6 billion (Q3 2025).